Literature DB >> 3541601

Microbial oncogenesis.

P A Mackowiak.   

Abstract

For more than a century, medical investigators have sought to incriminate microorganisms in the cause of cancer. The first scientific evidence of such a relationship came in 1911, with the first successful induction of a tumor using a cell-free extract. Since that time, considerable data have accrued linking retroviruses, herpes viruses, the hepatitis B virus, papovaviruses, and adenoviruses to various malignant neoplasms. There is also increasing evidence that certain bacteria and parasites participate as cofactors in the development of some cancers. Although proof of cause-and-effect relationships has been difficult to obtain, there can be little doubt that microorganisms occasionally play pivotal roles in the origin of some cancers. Whether attempted intervention against these cancers is best directed against the oncogenic microorganisms themselves or against other environmental cofactors is not yet clear. Nevertheless, the successful application of tumor vaccines in the prevention of Marek's disease in chickens and in modifying the outcome of oncogenic herpesvirus infections in nonhuman primates offers hope of at least limited application of microbial vaccines in the prevention of human cancer.

Entities:  

Mesh:

Year:  1987        PMID: 3541601     DOI: 10.1016/0002-9343(87)90381-0

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  3 in total

Review 1.  Host-pathogen interactions: redefining the basic concepts of virulence and pathogenicity.

Authors:  A Casadevall; L A Pirofski
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

Review 2.  Unconventional therapies for cancer: 6. 714-X. Task Force on Alternative Therapeutic of the Canadian Breast Cancer Research Initiative.

Authors:  E Kaegi
Journal:  CMAJ       Date:  1998-06-16       Impact factor: 8.262

Review 3.  Parallels between pathogens and gluten peptides in celiac sprue.

Authors:  Michael T Bethune; Chaitan Khosla
Journal:  PLoS Pathog       Date:  2008-02       Impact factor: 6.823

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.